人民卫生出版社系列期刊
ISSN 2096-2738 CN 11-9370/R

中国科技核心期刊(中国科技论文统计源期刊)
中国科学引文数据库(CSCD)来源期刊
《中国学术期刊影响因子年报》统计源期刊
美国化学文摘社(CAS)数据库收录期刊
日本科学技术振兴机构(JST)数据库收录期刊

新发传染病电子杂志 ›› 2025, Vol. 10 ›› Issue (6): 32-37.doi: 10.19871/j.cnki.xfcrbzz.2025.06.005

• 论著 • 上一篇    下一篇

HIV合并马尔尼菲篮状菌感染者并发贫血的流行特征及影响因素分析

覃如素1,2, 郑艳青1, 覃小英3, 吕建楠4, 黄天壬5, 卢亦波6, 邹俊1   

  1. 1.南宁市第四人民医院感染科,广西 南宁 530000;
    2.广西医科大学公共卫生学院,广西 南宁 530000;
    3.广西医科大学第二附属医院消化内科,广西 南宁 530000;
    4.右江民族医学院附属医院感染科,广西 百色 533000;
    5.广西医科大学附属肿瘤医院实验研究部,广西 南宁 53000;
    6.南宁市第四人民医院放射科,广西 南宁 530000
  • 收稿日期:2025-08-22 出版日期:2025-12-31 发布日期:2026-01-26
  • 通讯作者: 邹俊,Email:9134432@qq.com
  • 基金资助:
    1.国家自然科学基金资助项目(82360623); 2.南宁市兴宁区科学研究与技术开发项目(2022A11); 3.辉瑞基金项目(61417051)

Epidemiological characteristics and influencing factors of anemia in patients with HIV coinfected with Talaromyces marneffei

Qin Rusu1,2, Zheng Yanqing1, Qin Xiaoying3, Lyu Jiannan4, Huang Tianren5, Lu Yibo6, Zou Jun1   

  1. 1. Department of Infectious Diseases, The Fourth People's Hospital of Nanning, Guangxi Nanning 530000, China;
    2. School of Public Health, Guangxi Medical University, Guangxi Nanning 530000, China;
    3. Department of Gastroenterology, The Second Affiliated Hospital of Guangxi Medical University, Guangxi Nanning 530000, China;
    4. Department of Infectious Diseases, Affiliated Hospital of Youjiang Medical University for Nationalities, Guangxi Baise 533000, China;
    5. Experimental Research Department, Affiliated Tumor Hospital of Guangxi Medical University, Guangxi Nanning 530000, China;
    6. Department of Radiology, Nanning Fourth People's Hospital, Guangxi Nanning 530000, China
  • Received:2025-08-22 Online:2025-12-31 Published:2026-01-26

摘要: 目的 回顾性分析南宁市第四人民医院HIV合并马尔尼菲篮状菌(Talaromyces marneffei,TM)感染者临床数据,分析同时并发贫血的流行特征及探讨贫血影响因素,为临床风险分层和精准干预提供依据。方法 基于南宁市第四人民医院2012–2023年初次住院的HIV合并TM感染患者,按照纳入排除标准确定研究对象通过医院电子病历系统收集人口学、临床特征及实验室检查等数据,参照WHO贫血诊断标准分为贫血组与非贫血组及不同程度贫血亚组分类。比较贫血组与非贫血组患者流行病特征以及临床表现差异,运用多因素Logistic回归模型分析贫血影响因素。结果 本研究共纳入2296例HIV合并TM感染者,男性1841例(80.2%),女性455例(19.8%),年龄(45.19±14.41)岁。贫血患者1937例(84.4%),轻度贫血881例(45.5%),中度贫血887例(45.8%),重度贫血169例(8.7%)。贫血组患者年龄≥60岁、夏季发病、血培养阳性、血小板减少症患者占比高于非贫血组(P< 0.05)。贫血组CD3+T淋巴细胞、CD4+T淋巴细胞、CD8+T淋巴细胞计数显著低于非贫血组(P<0.05)。不同程度贫血患者之间在乏力、食欲不振、腹泻、消化道出血、肝脾肿大、淋巴结大、有无皮疹等临床体征方面差异有统计学意义(P<0.05)。多因素Logistic回归结果显示,TM血培养阳性(OR=1.410,95%CI:1.030~1.930)、年龄≥60岁(OR=1.702,95%CI:1.222~2.371)、血小板减少症(OR=1.928,95%CI:1.484~2.503)为贫血的危险因素,合并糖尿病(OR=0.322,95%CI:0.179~0.579)及CD4+T淋巴细胞计数升高(OR=0.637,95%CI:0.442~0.917)为保护因素。结论 HIV合并TM感染者贫血发生率高。随着贫血程度加重,可能出现肝脾及淋巴结肿大、皮疹等表现,需密切监测以及早期干预。临床上需关注高龄患者的TM血培养结果以及血小板和CD4+T淋巴细胞计数,警惕贫血带来的治疗和预后风险。

关键词: 人类免疫缺陷病毒, 马尔尼菲篮状菌, 贫血, 影响因素

Abstract: Objective This retrospective study analyzed data from patients co-infected with HIV and Talaromyces marneffei(TM) at Nanning Fourth People's Hospital. Its objectives were to compare the epidemiological differences between anemic and non-anemic cohorts, identify determinants influencing anemia development. The findings aim to inform clinical risk stratification and enable precision interventions. Method The study population consisted of HIV-infected patients with Talaromyces marneffei co-infection who were hospitalized for the first time at Nanning Fourth People’s Hospital between 2012 and 2023. Subjects were identified according to predefined inclusion and exclusion criteria. Demographic, clinical, and laboratory data were extracted from the hospital’s electronic medical record system. Anemia status was assigned using the WHO diagnostic criteria, permitting categorization into anemic and non-anemic groups and further stratification by anemia severity. Statistical analyses were performed with SPSS 25.0. Inter-group differences in epidemiological characteristics and clinical manifestations were assessed by univariate methods including t test, X2 test, and non-parametric tests as appropriate. Multivariable Logistic regression was used to identify independent determinants of anemia. Result A total of 2296 HIV/TM co-infected patients admitted to Nanning Fourth People’s Hospital between 2012 and 2023 were enrolled. The cohort comprised 1841 (80.2%) males and 455(19.8%) females, with a mean age of (45.19±14.41) years. Anemia was present in 1937 patients(84.4%), among these, 881(45.5%) had mild, 887(45.8%) moderate, and 169(8.7%) severe anemia. Compared with non-anemic subjects, anemic patients exhibited higher proportions of individuals aged ≥60 years, disease onset during summer, positive TM blood cultures, and thrombocytopenia (all P<0.05). Lymphocyte subset analyses revealed that CD3+, CD4+, and CD8+ T-cell counts were significantly lower in the anemia group (P<0.05).Across anemia severity strata, significant differences were observed in the frequencies of fatigue, anorexia, diarrhea, gastrointestinal bleeding, hepatosplenomegaly, lymphadenopathy, and skin rash (P<0.05).Multivariable Logistic regression identified the following independent risk factors for anemia: positive TM blood culture (OR=1.410, 95%CI: 1.030-1.930), age≥60 years (OR=1.702, 95%CI:1.222-2.371), and thrombocytopenia (OR=1.928, 95%CI: 1.484-2.503). Conversely, concomitant diabetes mellitus(OR=0.322, 95%CI: 0.179-0.579) and higher CD4+ T-cell counts(OR=0.637, 95%CI:0.442-0.917) were associated with a reduced risk. Conclusion Among HIV/Talaromyces marneffei co-infected patients, the incidence of anemia is markedly elevated. As anemia severity increases, manifestations such as hepatosplenomegaly, lymphadenopathy, and cutaneous eruptions become more prevalent, necessitating vigilant monitoring for early intervention. In clinical practice, particular attention should be directed to older patients, with close tracking of T. marneffei blood-culture results, platelet counts, and CD4+ T-cell levels to promptly recognize and mitigate the therapeutic and prognostic risks imposed by anemia.

Key words: Human Immunodeficiency Virus, Talaromyces marneffei, Anemia, Influencing Factors

中图分类号: